Tuesday, August 9, 2022
Jamp Pharma Corporation is recalling a lot of Jamp Atorvastatin 40 mg tablets due to possible latex contamination.
A Health Canada advisory said a piece of latex was found in one Atorvastatin tablet in lot MHC1403A.
The department urged those taking Atorvastatin—commonly used to treat high cholesterol and prevent heart attacks—to double-check with a pharmacy to see if the tablets are from the affected lot.
Ingesting latex could lead to anaphylaxis, it said.
Health Canada added it is monitoring the Boucherville, Que., company's recall "and will inform Canadians if any new health risks are identified."
Other drugs recall
Drug recall: Magnesium Citrate Oral Solution recalled due to this reason
Drug recall: Propofol Injectable Emulsion recalled due to this reason
Drug recall: Insulin Glargine Injection Pens recalled due to this reason
Drug recall: Morphine Sulfate 30 mg, 60 mg Extended Release Tablets recalled due to this reason
Drug recall: Over 6 lakh bottles of Blood Pressure treatment tablets recalled
Drug recall: 2.1 million doses of medicine recalled due to this reason
Govt to Create 219 Jobs for Drug Inspectors, Senior Officials to regulate Medical Devices in India
FDA raided: Fake Cosmetic manufacturing factory busted
PCI should revise B Pharm curriculum as per NEP 2020: Expert
USFDA declines to approve expanded use of this Antipsychotic drug
USFDA gives final approval for Empagliflozin tablets
FDA Haryana busted a fake medicine factory
FDA Maharashtra seizes diagnostic kits being sold without license
9th edition of Indian Pharmacopoeia released: Details
Govt is set to ban Codeine-based Cough Syrups and formulations
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/08/08/drug-recall-atorvastatin-40-mg-tablets-recalled-due-to-this-reason/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment